Iridex (IRIX) Net Income (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 38.64% |
| Jan 3, 2026 | 409.35% |
| Sep 27, 2025 | -58.25% |
| Jun 28, 2025 | 41.04% |
| Mar 29, 2025 | -121.48% |
| Dec 28, 2024 | 506.00% |
| Sep 28, 2024 | 27.85% |
| Jun 29, 2024 | 22.66% |
| Mar 30, 2024 | -151.59% |
| Dec 30, 2023 | 482.78% |
| Sep 30, 2023 | 36.59% |
| Jul 1, 2023 | -32.34% |
| Apr 1, 2023 | -72.73% |
| Dec 31, 2022 | 31.52% |
| Oct 1, 2022 | 21.15% |
| Jul 2, 2022 | 6.27% |
| Apr 2, 2022 | -138.81% |
| Jan 1, 2022 | 384.53% |
| Oct 2, 2021 | -255.42% |
| Jul 3, 2021 | 169.30% |
| Sep 26, 2020 | 38.17% |
| Jun 27, 2020 | -68.38% |
| Mar 28, 2020 | -123.08% |
| Dec 28, 2019 | 500.67% |
| Sep 28, 2019 | 26.21% |
| Jun 29, 2019 | 20.64% |
| Mar 30, 2019 | -131.05% |
| Dec 29, 2018 | 419.29% |
| Sep 29, 2018 | 6.28% |
| Jun 30, 2018 | 8.96% |
| Mar 31, 2018 | 30.11% |
| Dec 30, 2017 | -66.51% |
| Sep 30, 2017 | -12.58% |
| Jul 1, 2017 | -47.37% |
| Apr 1, 2017 | 82.75% |
| Dec 31, 2016 | -1,511.77% |
| Oct 1, 2016 | -104.57% |
| Jul 2, 2016 | -424.75% |
| Apr 2, 2016 | 112.63% |
| Jan 2, 2016 | -281.00% |
| Oct 3, 2015 | 167.79% |
| Jul 4, 2015 | -365.04% |
| Sep 27, 2014 | 64.98% |
| Jun 28, 2014 | -39.01% |
| Mar 29, 2014 | 18.20% |
| Dec 29, 2012 | 1,302.63% |
| Mar 31, 2012 | -195.86% |
| Oct 2, 2010 | 11.79% |